These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15207628)

  • 1. Analysis of murine leukemia virus replication complemented by yeast tRNA(Phe) reveals inherent preferences for the tRNA primer selected for reverse transcription.
    Palmer MT; Morrow CD
    Virology; 2004 Jul; 324(2):430-8. PubMed ID: 15207628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine leukemia virus with a primer-binding site complementary to tRNALys,3 adapts to select new tRNAs for replication following extended in vitro culture.
    Palmer MT; McPherson S; Morrow CD
    Virology; 2005 Mar; 333(2):337-48. PubMed ID: 15721366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementarity between 3' terminal nucleotides of tRNA and primer binding site is a major determinant for selection of the tRNA primer used for initiation of HIV-1 reverse transcription.
    Yu Q; Morrow CD
    Virology; 1999 Feb; 254(1):160-8. PubMed ID: 9927583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
    Kang SM; Wakefield JK; Morrow CD
    Virology; 1996 Aug; 222(2):401-14. PubMed ID: 8806524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast tRNA(Phe) expressed in human cells can be selected by HIV-1 for use as a reverse transcription primer.
    Kelly NJ; Morrow CD
    Virology; 2003 Sep; 313(2):354-63. PubMed ID: 12954204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the interaction between tRNA and primer binding site from characterization of a unique HIV-1 virus which stably maintains dual PBS complementary to tRNA(Gly) and tRNA(His).
    Li Y; Zhang Z; Kang SM; Buescher JL; Morrow CD
    Virology; 1997 Nov; 238(2):273-82. PubMed ID: 9400600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers.
    Modin C; Lund AH; Schmitz A; Duch M; Pedersen FS
    Virology; 2000 Dec; 278(2):368-79. PubMed ID: 11118360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
    Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
    Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
    Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
    Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.
    Mbisa JL; Nikolenko GN; Pathak VK
    J Virol; 2005 Jan; 79(1):419-27. PubMed ID: 15596835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.
    Wakefield JK; Rhim H; Morrow CD
    J Virol; 1994 Mar; 68(3):1605-14. PubMed ID: 7508999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.
    Li X; Mak J; Arts EJ; Gu Z; Kleiman L; Wainberg MA; Parniak MA
    J Virol; 1994 Oct; 68(10):6198-206. PubMed ID: 7521916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations within the primer binding site of the human immunodeficiency virus type 1 define sequence requirements essential for reverse transcription.
    Wakefield JK; Morrow CD
    Virology; 1996 Jun; 220(2):290-8. PubMed ID: 8661380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.
    Lund AH; Duch M; Pedersen FS
    Nucleic Acids Res; 2000 Feb; 28(3):791-9. PubMed ID: 10637332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. tRNA isoacceptor preference prior to retrovirus Gag-Pol junction links primer selection and viral translation.
    Palmer MT; Kirkman R; Kosloff BR; Eipers PG; Morrow CD
    J Virol; 2007 May; 81(9):4397-404. PubMed ID: 17301132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription.
    Rhim H; Park J; Morrow CD
    J Virol; 1991 Sep; 65(9):4555-64. PubMed ID: 1714513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis.
    Kelly NJ; Palmer MT; Morrow CD
    J Virol; 2003 Aug; 77(16):8695-701. PubMed ID: 12885888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine 222, a member of the YXDD motif of MuLV RT, is catalytically essential and is a major component of the fidelity center.
    Kaushik N; Singh K; Alluru I; Modak MJ
    Biochemistry; 1999 Mar; 38(9):2617-27. PubMed ID: 10052931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV plus-strand transfer reaction: determination of replication-competent intermediates and identification of a novel lentiviral element, the primer over-extension sequence.
    Muthuswami R; Chen J; Burnett BP; Thimmig RL; Janjic N; McHenry CS
    J Mol Biol; 2002 Jan; 315(3):311-23. PubMed ID: 11786014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.